Article By:
Benzinga
Tuesday, December 8, 2020 12:29 PM EDT
Curis, Inc. shares were skyrocketing Tuesday on above-average volume after the company announced updated Phase 1 data on its investigational asset CA-4948 in treating acute myeloid leukemia and myelodysplastic syndromes.
In this article: CRIS